Marken Inaugurates New Branch in India
Marken continues their expansion of services in India, by augmenting their existing Mumbai facility with four additional branches to support the growing demand in clinical trial logistics within India. The expansion in New Delhi, Hydrabad, Pune and Bangalore will support the growing need for temperature controlled logistics of sensitive drugs and cold chain specimens. As part of their expansion in India, Marken recently ran a special client Awareness workshop on the air transport of infectious substances.
Marken is implementing their stated plan to build the most advanced, fit for purpose clinical Supply chain network to serve the pharmaceutical community. The new India offices build on Marken’s current clinical trial support services and enable the company to grow from its current industry-leading life sciences logistics platform. Marken is expanding their reach throughout India to support their clients rapidly increasing demand for supply chain management services of Active Pharmaceutical Ingredients (API), Investigational Medical Products (IMPs) and Clinical Trial Specimens.
“The expansion of our operations in India enables Marken to better support our clients’ need for regional expertise and temperature controlled supply chain services.” said Wes Wheeler, Marken’s Chief Executive Officer. “We have seen steady growth and demand of our specimen logistics, drug distribution and API supply chain services in India.”
Marken is currently developing a new purpose-built GMP compliant depot in Bangalore due to be complete by the end of 2012. The Bangalore Depot will join Marken’s already operational Argentina, Mexico and Singapore depots offering the full range of temperature controlled storage capabilities including: controlled ambient, refrigerated and frozen as Pharmaceuticals and Medical devices. Each of Marken’s depots provides drug and equipment distribution solutions including: Pick & Pack, relabeling services, reverse logistics, reconciliation and certified destruction. Additionally, the network manages specimen kit distribution, interim specimen storage and management.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
